본문 바로가기

β-Catenin and AMPK/AKT/FOXO Signaling Mediate Doxorubicin-Induced Senescence and Lipid Accumulation in C2C12 Myoblasts

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q2Scopus Q2KCI Q1
저널
Biomolecules & Therapeutics34(1) · pp.136 · 2026
피인용
Web of Science 2Scopus 3KCI 0
FWCI (Scopus)
4.87
JCR IF
JCR 2024 3.2
ISSN
1976-9148

저자

  1. 윤차원제1저자Pusan Natl Univ, Res Inst Drug Dev, Coll Pharm, Dept Pharm, Busan 46241, South Korea
  2. 김소현Pusan Natl Univ, Res Inst Drug Dev, Coll Pharm, Dept Pharm, Busan 46241, South Korea
  3. Kwon, DoyoungJeju Natl Univ, Jeju Res Inst Pharmaceut Sci, Coll Pharm, Jeju 63243, South Korea
  4. 우란주Pusan Natl Univ, Res Inst Drug Dev, Coll Pharm, Dept Pharm, Busan 46241, South Korea
  5. 정기웅Pusan Natl Univ, Res Inst Drug Dev, Coll Pharm, Dept Pharm, Busan 46241, South Korea
  6. 이재원Pusan Natl Univ, Res Inst Drug Dev, Coll Pharm, Dept Pharm, Busan 46241, South Korea
  7. Lee, Yun-Hee교신저자Seoul Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Seoul 08826, South Korea
  8. 정영석교신저자Pusan Natl Univ, Res Inst Drug Dev, Coll Pharm, Dept Pharm, Busan 46241, South Korea

초록

Skeletal muscle atrophy is a major complication associated with aging, chronic disease, and chemotherapy. Doxorubicin (Dox), a widely used anticancer agent, accelerates muscle wasting; however, the underlying cellular mechanisms remain poorly understood. In this study, we examined the effects of Dox on myogenic differentiation, senescence, and lipid metabolism using C2C12 myoblasts. Dox exposure impaired myotube formation without causing overt cytotoxicity. Mechanistically, Dox disrupted myogenic differentiation by inhibiting protein kinase B/mammalian target of rapamycin (AKT/mTOR) signaling, thereby de-repressing forkhead box O1/3 (FOXO1/3) and upregulating the muscle-specific ubiquitin ligases muscle atrophy F-box (MAFbx) and muscle RING finger 1 (MuRF1), which promote proteolysis. Dox also decreased glycogen synthase kinase 3β (GSK3β) phosphorylation while paradoxically increasing total and phosphorylated β-catenin, indicating dysregulated Wnt/β-catenin signaling. These alterations were accompanied by a senescence-like phenotype, characterized by elevated senescence-associated β-galactosidase (SA-β-gal) activity, increased phosphorylated histone variant γH2AX, and activation of the p53–p21 axis. Notably, cellular senescence coincided with excessive lipid accumulation in myotubes. Dox reduced phosphorylation of adenosine monophosphate-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC) while enhancing expression of key lipogenic regulators, thereby creating a metabolic environment favoring lipid storage. Collectively, these findings demonstrate that Dox not only suppresses myogenic differentiation but also induces premature senescence and metabolic reprogramming toward lipid accumulation. Targeting these pathways through AMPK activation, FOXO inhibition, or senolytic interventions may offer therapeutic strategies to preserve skeletal muscle integrity in patients undergoing chemotherapy.

키워드

Doxorubicinβ-CateninAMPKAKTFOXOSenescence

식별자

Scopus EID
2-s2.0-105028118143
WoS UID
001666205800008
KCI
ART003291044